Final Review of General Practice Incentives report revealed It recommends a suite of changes which, if accepted, would see GPs’ incentives undergo a major shakeup, including a new payment architecture and a shift in the foundation of general practice.
Action taken amid continuing PrEP shortage As supply of the HIV prevention medication continues to be disrupted, the Federal Government has listed a US brand on the PBS to shore up access.
City PBS prescription rates double those in very remote areas One GP says there simply are not enough remote doctors, as new data finds the people living there are accessing medication at a much lower rate.
Admin burden top reason GPs plan to leave practice: RACGP In a ‘wakeup call’ for governments, the new Health of the Nation report found 70% of GPs are concerned about their admin workload.
PBS additions for cancer and epilepsy Tens of thousands of patients each year are set to benefit from several first-time additions, including Zyamis and Tecentriq SC.
RACGP represents on national climate change expert group GPs continue to lead the charge of warning of the health impacts of climate change, as a college Chair is appointed to the new group.
GP incentives review ‘nothing but disrespectful’ The RACGP President lashed out at its recommended new payment architecture, saying it ignores GPs’ advice and devalues the profession.
Wegovy launches in Australia The manufacturer assured GPs supply planning has been its priority amid critical Ozempic shortages, but concerns remain over Wegovy’s availability.
Cystic fibrosis medication expanded on PBS Doctors can soon prescribe subsidised Trikafta to children earlier, in a ‘lifechanging’ move set to save families $250,000 each year.
Sweeping change needed amid ‘diabetes epidemic’: Inquiry The RACGP says prevention is key, as Medicare reform, bolstered rural access, sugar taxes, and CGM subsidies were all recommended.